Most Recent
A judge has signed off on a $16 million settlement in a class action against Dixon Advisory, but the funder of a competing case that was stayed after losing a beauty parade has earned a fragment of the $1 million it sought from the resolution sum.
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.
The High Court is set to weigh in on a challenge to a precedent-setting decision that found breaches of statutory duty under a provision of the Design and Building Practitioners Act are not apportionable, in a case with significant ramifications for the NSW construction industry.
The entity in charge of a $511 million waste-to-energy plant south of Perth has filed a second lawsuit against Acciona, accusing the Spanish infrastructure giant of withholding $38.6 million in bank guarantees to use as leverage in unrelated disputes about the troubled project.
Clorox has been taken to court for alleged greenwashing, with the ACCC claiming the consumer goods giant misled customers into believing that a line of its GLAD trash bags were sourced from plastic recycled from the ocean.
The NSW Court of Appeal has said it has no power to exclude group members who do not sign up to a class action from participating in a settlement, upholding a controversial decision that the Full Federal Court said was “plainly wrong”.
A court has given the green light to BHP’s bid to extend a Queensland coal mine over the objections of an environmental lobby group, saying the court’s acceptance of climate change did not mean it would reject all applications for fossil fuel projects.
The Full Court has clarified that a prior bad reputation is relevant to determining whether a defamation plaintiff has suffered serious harm, tossing an appeal by a Sydney lawyer who lost her case over an article related to her conviction for an alleged $16,000 scam at David Jones, which was later overturned.
A group of surgeons who worked for The Cosmetic Institute are set to pay $25 million to settle a class action brought on behalf of 13,500 patients who claim they were injured by botched breast augmentation surgery.
A commercial leader at engineering and construction company Laing O’Rourke was unfairly dismissed over false claims he was offensive and aggressive towards Stayz hosts who complained about a late night work party, a judge has found.